Archive · 4 Aug 2025
Concept Medical Starts Heart Trial for New Coronary Treatment
Doctors are testing a new treatment for small blood vessels in the heart.
They are using a special balloon covered in medicine to treat blockages.
This new method is called MagicTouch.
The trial, called MAGICAL-SV, involves doctors in the US and Europe.
They will compare the new balloon with current treatments that use metal tubes called stents.
The study will involve many patients to see if the new balloon works as well or better than the stents.
The aim is to create a new way to help people with heart problems that is better than the old ways.
The new technique does not leave metal inside the body.
Concept Medical enrolled its first patient in the MAGICAL-SV trial, a study for small coronary vessels.
The trial evaluates the MagicTouch sirolimus-coated balloon (SCB) against drug-eluting stents.
The study aims to enroll 1,605 patients across the U.S. and Europe.
The trial is led by an international team of cardiologists.
The goal is to gather evidence for the SCB and potentially transform coronary artery disease treatment.
- Who
- The trial is led by an international team of cardiologists and is sponsored by Concept Medical.
- What
- Concept Medical is enrolling patients in the MAGICAL-SV trial for a sirolimus-coated balloon for coronary artery lesions.
- When
- The first patient enrollment was recently announced.
- Where
- The trial is being conducted in the U.S. and Europe.
- Why
- To evaluate the efficacy of MagicTouch SCB as a potential alternative to drug-eluting stents for small coronary artery lesions.
Supporters of MagicTouch SCB
Supporters of Drug-Eluting Stents
Treatment Strategy
Supporters of MagicTouch SCB
Sirolimus-coated balloons offer a potential metal-free PCI strategy that may offer safer, more effective options.
Supporters of Drug-Eluting Stents
The benefits of DES are well-established in treating coronary artery disease and offer proven outcomes.
- Trial Name
- MAGICAL-SV
- Device Being Tested
- MagicTouch sirolimus-coated balloon (SCB)
- Treatment Target
- Small coronary artery lesions
- Comparison
- Drug-eluting stents
- Enrollment Goal
- 1,605 patients
- Primary Endpoint
- Target lesion failure (TLF) at 12 months
- Company
- Concept Medical